Home›Antibody-drug conjugates›德曲妥珠單抗🌐中文EnglishEspañolItalianoPortuguêsРусскийالعربيةفارسی中文日本語MedicationQ80109553· pop 11· linked from 657 articles德曲妥珠單抗Also known as fam-trastuzumab deruxtecan, Enhertu, DS-8201a, DS-8201medicationClinical Trials142 registeredPHASE1NOT_YET_RECRUITINGPhase 1b Study Of TRICK-NK In Combination With T-Dxd In Treatment-Refractory Breast CancersM.D. Anderson Cancer Center · NCT07553390PHASE2RECRUITINGDeveloping ctDNA Guided Adjuvant Therapy for Gastrooesophageal CancerUniversity of Southampton · NCT05965479PHASE3RECRUITINGA Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast CancerJazz Pharmaceuticals · NCT06435429COMPLETEDAvailable in 11 languagesEspañol中文日本語РусскийPortuguêsItalianoالعربيةOdiaUkrainianConnectionsErb-b2 receptor tyrosine kinase 2Proteinfusion proteinEntityCategoriesAntibody-drug conjugatesChemical pages without ChemSpiderIDDaiichi SankyoDrugs developed by AstraZenecaDrugs that are a monoclonal antibodyDrugs with non-standard legal statusMonoclonal antibodies for tumorsOrphan drugsSource attribution